Advertisement

Peritoneal Dialysis in Developing Countries

  • G. Abraham
  • B. Pratap
  • A. Gupta

While globalization may be the flavor of the day, it is equally important to look at the social side of economic operations. Trade liberalization by developed countries could boost income prospects in developing economies.

Keywords

Peritoneal Dialysis Coronary Artery Calcium Score Continuous Ambulatory Peritoneal Dialysis Peritoneal Dialysis Patient Catheter Removal 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Wang T, Abraham G, Akiba T, Blake P, Gokal R, et al. Peritoneal dialysis in Asia in the 21st century: Perspectives on and obstacles to peritoneal dialysis therapy in Asian countries. Perit Dial Int 2002; 22: 243–248.PubMedGoogle Scholar
  2. 2.
    Kawanishi H, Hashimoto Y, Nakamoto H, Nakayama M, Tranaeus A. Combination therapy with peritoneal dialysis and hemodialysis. Perit Dial Int 2006; 26: 150–154.PubMedGoogle Scholar
  3. 3.
    McIntyre CW. Bimodal dialysis: An integrated approach to renal replacement therapy. Perit Dial Int 2004; 24: 547–553.PubMedGoogle Scholar
  4. 4.
    Rashid HU, Azhar MA, Rahman A. Management of end stage renal disease with intermittent peritoneal dialysis. Perit Dial Bull 1986; 6: 214.Google Scholar
  5. 5.
    Trevino-Becerra A. Intermittent peritoneal dialysis with a cycler may be the answer. Perit Dial Bull 1984; 4: 112.Google Scholar
  6. 6.
    Tripathi K, Jai Prakash. Peritoneal Dialysis in post-abdominal surgery in elderly patients developing acute renal failure. Perit Dial Bull 1987; 7: s78.Google Scholar
  7. 7.
    Phu NH, Hien TT, Mai NT, Chau TT, Chuong LV, Loc PP, Winearls C, Farrar J, White N, Day N. Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam. N Engl J Med 2002; 347: 895–902.PubMedGoogle Scholar
  8. 8.
    Balasubramaniyam R, Prem Anand K, Panda B, Fatema S, Nirmala VR, Srinivasan C, Priya V. Our initial experience on peritoneal dialysis for acute renal failure in neonates. Indian J Perit Dial 2006; 10: 8–11.Google Scholar
  9. 9.
    Shah MA, Prasad S, Masare SP. Acute peritoneal dialysis for acute renal failure in infants immediately following laparotomy. Indian J Perit Dial 2006; 11: 32–34.Google Scholar
  10. 10.
    Mohandas N, Chellapandian D. Value of intermittent peritoneal dialysis in rural setup. Indian J Perit Dial 2004; 6: 19–20.Google Scholar
  11. 11.
    Samad MA, Iqbal S, Rashid HU, et al. CAPD: experience in Bangladesh. Indian J Perit Dial 2006; 10: 28–29.Google Scholar
  12. 12.
    Hussain R, Tufail M, Naqvi SAJ. CAPD as a model of RRT in children and adults – Pakistan experience. Indian J Perit Dial 2006; 11: 10–13.Google Scholar
  13. 13.
    Wang X, Lu X, Wang T. Peritoneal dialysis versus hemodialysis: how Chinese patients choose their dialysis modality? Indian J Perit Dial 2006; 10: 12–15.Google Scholar
  14. 14.
    Sharma SK, Singh J, Koirala B, Gautam M, et al. Peritoneal dialysis in Eastern Nepal. Perit Dial Int 2002; 22 (suppl. 2): Abstract S53.Google Scholar
  15. 15.
    UdayKumar TR, Amlaraja A, Soundararajan P, Abraham G. Level of stress and coping abilities in patients on chronic hemodialysis and chronic peritoneal dialysis. Indian J Nephrol 2003; 13: 89–91.Google Scholar
  16. 16.
    Bapat U, Nayak SG, Prashanth GK, Gokulnath. Coping strategies and perceived social supports of ESRD patients on CAPD (A cross sectional study). Indian J Perit Dial 2003; 11: 19–22.Google Scholar
  17. 17.
    Maiorca R, Maggiore R, Mordacci E, et al. Ethical problems in dialysis and transplantation. Nephrol Dial Transplant 1996; 11 (suppl. 9): 100–112.PubMedGoogle Scholar
  18. 18.
    Healthcare in India – The Road Ahead: A Report by CII-McKinsky and Company, 2002: 1, 2.Google Scholar
  19. 19.
    Thiagarajan T, Mathew M, Soundararajan P, Ramalakshmi R, Abraham G. Clinical outcome and cost effectiveness of bed-side permanent catheter implantation in a resource scarce facility in South India. Indian J Perit Dial 2006; 10: 16–20.Google Scholar
  20. 20.
    Shroff S. Permanent peritoneal dialysis catheter implantation. Indian J Perit Dial 2006; 10: 21–27.Google Scholar
  21. 21.
    Fleisher AG, Kimmelstiel FM, Lattes CG, Miller RE. Surgical complications of peritoneal dialysis catheters. Am J Surg 1985; 149: 726–729.PubMedGoogle Scholar
  22. 22.
    Ash SR. Chronic peritoneal dialysis catheters: overview of design, placement and removal procedures. Semin Dial 2003; 16: 323–334.PubMedGoogle Scholar
  23. 23.
    Padma, Edwin B, Suresh S, Mathew M, Abraham G, Soundarajan P, Shroff S. Permanent peritoneal dialysis catheter malfunction: Our experience. Indian J Perit Dial 2000; 3: 22–24.Google Scholar
  24. 24.
    Jorres A, Bender TO, Witowski J. Glucose degradation products and the peritoneal mesothelium. Perit Dial Int 2000; 20 (suppl. 5): S19–S22.PubMedGoogle Scholar
  25. 25.
    Lage C, Pischetsrieder M, Aufricht C, et al. First in vitro and in vivo experiences with stay-safe balance, a pH-neutral solution in a dual-chambered bag. Perit Dial Int 2000; 20 (suppl. 5): S28–S32.PubMedGoogle Scholar
  26. 26.
    Park MS, Kim JK, Holmes C, Weiss MF. Effects of bicarbonate/lactate solution on peritoneal advanced glycosylation end-product accumulation. Perit Dial Int 2000; 20 (suppl. 5): S33–S38.PubMedGoogle Scholar
  27. 27.
    Garcia-Lopez E, Lindholm B, Tranaeus A. Biocompatibility of new peritoneal dialysis solutions: Clinical experience. Perit Dial Int 2000; 20 (suppl. 5): S48–S56.PubMedGoogle Scholar
  28. 28.
    Rozenberg R, Magen E, Weissgarten J, Korzets Z. Icodextrin-induced sterile peritonitis: the Israeli experience. Perit Dial Int 2006; 26: 402–405.PubMedGoogle Scholar
  29. 29.
    Moberly JB, Mujais S, Gehr T, Hamburger R, Sprague S, Kucharski A, et al. Pharmacokinetics of icodextrin in peritoneal dialysis patients. Kidney Int Suppl 2002; 81: s23–S33.PubMedGoogle Scholar
  30. 30.
    Davies SJ, Woodrow G, Donovan K, Plum J, et al. Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol 2003; 14: 2338–2344.PubMedGoogle Scholar
  31. 31.
    Rippe B, Simonsen O, Heimburger O, CHristensson A, et al. Long-term clinical effects of peritoneal dialysis fluid with less glucose degradation products. Kidney Int 2001; 59: 348–357.PubMedGoogle Scholar
  32. 32.
    Morgan LW, Wieslander A, Davies M, Horiuchi T, Ohta Y, et al. Glucose degradation products retard remesothelialization independently of D-glucose concentration. Kidney Int 2003; 64: 1854–1866.PubMedGoogle Scholar
  33. 33.
    Catalan MP, Santamaria B, Reyero A, Ortiz A, et al. 3,4-Di-deoxyglucosone-3-ene promotes leukocyte apoptosis. Kidney Int 2005; 68: 1303–1311.PubMedGoogle Scholar
  34. 34.
    Sezer TS. Amino acid-based PD solutions are effective and safe in the treatment of malnutrition. Perit Dial Int 2004; 24(suppl. 2): Abstract S68.Google Scholar
  35. 35.
    Yao Q, Pawlaczyk K, Kuzlan-Pawlaczyk M, et al. Physiological solutions may prevent peritoneal fibrosis in chronic dialysis rats. Perit Dial Int 2004; 24(suppl. 2): Abstract S69.Google Scholar
  36. 36.
    Kumar R, Abraham G, Padma G, et al. Peritoneal equilibration test in a CAPD population. Indian J Perit Dial 1998; 1: 34–36.Google Scholar
  37. 37.
    Naga SS, El-Belbessi A. Peritoneal equilibration test (PET) in acute peritoneal dialysis (APD). Perit Dial Int 1998; 18 (suppl. 2): S3.Google Scholar
  38. 38.
    Sirivongs D, Chunlertrith D, Seetaso K. A modified PET for small size CAPD patients. Perit Dial Int 1998; 18 (suppl. 2): S3.Google Scholar
  39. 39.
    Wang NS, Tong LQ, Gao XP, et al. Clinical use of PET, Kt/V and PCR in peritoneal dialysis patients. Perit Dial Int 1998; 18 (suppl. 2): S6.Google Scholar
  40. 40.
    Lye WC, vander Straaten JC, Leong SO, et al. A cross sectional study on adequacy of dialysis, peritoneal equilibration test and nutrition in Asian CAPD patients. Perit Dial Int 1998; 18 (suppl. 2): S3.Google Scholar
  41. 41.
    Gopalakrishnan R, Tan SH, Ho CK. The association between clinical characteristics and peritoneal transport status in a single center in Singapore. Indian J Perit Dial 2005; 8: Abstract S24.Google Scholar
  42. 42.
    Sharma RK, Kohli R, Gupta A, Ahmed M, Singh U. Membrane transport characteristic in Indian patients on CAPD: effects on patient outcome. Indian J Perit Dial 2005; 8: Abstract S23.Google Scholar
  43. 43.
    Cueto-Manzano AM, Diaz-Alvarenga A, Correa-Rotter A. Analysis of the peritoneal equilibration test in Mexico and of factors influencing the peritoneal transport rate. Perit Dial Int 1999; 19: 45–50.PubMedGoogle Scholar
  44. 44.
    Agarwal DK, et al. Peritoneal equilibriation test in Indian patients on CAPD. Does it affect patient outcome? Adv Perit Dial 2000; 16: 148–151.PubMedGoogle Scholar
  45. 45.
    Gupta KL, Reddy SR, Jha V, Kohli HS, Singh SK. Prevalence of high transport status in Indian peritoneal dialysis patients is not necessarily high. Perit Dial Int 2002; 22 (suppl. 2): Abstract S15.Google Scholar
  46. 46.
    Shetty M, Annigeri RA, Prakash KC, Subba Rao B. Relation between serum C-reactive protein (CRP) and peritoneal membrane solute transport characteristics in Indian chronic peritoneal dialysis patients. Indian J Perit Dial 2005; 9: 8–10.Google Scholar
  47. 47.
    Cueto-Manzano AM, Gamba G, Abasta-Jimenez M, Correa-Rotter R. Consistency of the peritoneal equilibration test in a cohort of non selected Mexican CAPD patients. Adv Perit Dial 1995; 11: 114–118.PubMedGoogle Scholar
  48. 48.
    Gonzalez-Espinoza L, Gutierrez-Chavez J, del Campo FM, Martinez-Ramirez HR, et al. Randomized, open label, controlled clinical trial of oral administration of an egg albumin-based protein supplement to patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 2005; 25: 173–180.PubMedGoogle Scholar
  49. 49.
    Peers E, Gokal R. Icodextrin: overview of clinical experience. Perit Dial Int 1997; 17: 22–26.PubMedGoogle Scholar
  50. 50.
    Lo WK, Bargman JM, Burkart J, Krediet RT, Pollock C, Kawanishi H, Blake PG. ISPD Guidelines/Recommendations: guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis. Perit Dial Int 2006; 26: 520–522.PubMedGoogle Scholar
  51. 51.
    Pagiagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, et al. Effect of increased peritoneal clearances on mortality in peritoneal dialysis: ADEMEX, a prospective randomized control trial. J Am Soc Nephrol 2002; 13: 1307–1320.Google Scholar
  52. 52.
    Lo WK, Ho YW, Li CS, Chan TM, et al. Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study. Kidney Int 2003; 64: 649–656.PubMedGoogle Scholar
  53. 53.
    Dombros N, et al. European Best practice guidelines for peritoneal dialysis. EBPG Expert Group on Peritoneal Dialysis. Nephrol Dial Transplant 2005; (suppl. 9): ix1–ix37.Google Scholar
  54. 54.
    Georgi Abraham, Milly Mathew, Padma G, Suresh S, Shroff S. Are three exchanges suitable for Asian patients on peritoneal dialysis? Perit Dial Int 2003; 23 (suppl. 2): S37–S39.Google Scholar
  55. 55.
    Lam MF, Tang C, Wong AK, Tong KL, et al. ASPD: a prospective study of adequacy in Asian patients on long term, small volume continuous ambulatory peritoneal dialysis. Perit Dial Int 2006; 26 (4): 466–474.PubMedGoogle Scholar
  56. 56.
    Popovich RP, Moncrief JW, Nolph KD, et al. Continuous ambulatory peritoneal dialysis. Ann Intern Med 1978; 88: 449–452.PubMedGoogle Scholar
  57. 57.
    Warady BA, Fivush BA, Alexander SR. Peritoneal dialysis. In: Baratt TM, Avner ED, Harmon WE, eds. Pediatric Nephrology. 4th Ed., Baltimore: Williams and Wilkins; 1999: 1251–1265.Google Scholar
  58. 58.
    Fischbach M, Terzic J, Menouer S, Bergere V, Ferjani L, Haraldsson B. Impact of fill volume changes on peritoneal dialysis tolerance and effectiveness in children. Adv Perit Dial 2000; 16: 321–223.PubMedGoogle Scholar
  59. 59.
    Fischbach M, Terzic J, Becmeur F, et al. Relationship between intraperitoneal hydrostatic pressure and dialysate volume in children on PD. In: Khanna R, ed. Advances in Peritoneal Dialysis. Toronto: Peritoneal Dialysis Publications, 1996; 12: 330–334.Google Scholar
  60. 60.
    Fischbach M, Terzic J, Dangelser C, Schneider P, Roger ML, Geisert J. Effect of posture on intraperitoneal pressure and peritoneal permeability in children. Pediatr Nephrol 1998; 12: 311–314.PubMedGoogle Scholar
  61. 61.
    Iyengar AA, Vasudevan A, Phadke KD. Chronic PD in children – The Bangalore experience. Indian J Perit Dial 2005; 8: 17–19.Google Scholar
  62. 62.
    Donmez O, Aladag S, Cigerdelen N, Kocak S. Outcome in children on chronic peritoneal dialysis. Adv Perit Dial 2003; 19: 269–272.PubMedGoogle Scholar
  63. 63.
    Warady BA, Hebert D, Sullivan EK, Alexander SR, Tejani A. Renal transplantation, chronic dialysis and chronic renal insufficiency in children and adolescents. The 1995 Annual Report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 1997; 11: 49–64.PubMedGoogle Scholar
  64. 64.
    Arbeiter K, Vescei A, Mueller T, Sinz C, Balazar E, Aerfricht C. Chronic peritoneal dialysis in children. Results of the Vienna Pediatric Dialysis Department. Wienklin Wochenschr 2003; 115: 660–664.Google Scholar
  65. 65.
    Piraino B, Perlmutter JA, Holley JL, Bernardini J. Staphylococcus aureus peritonitis is associated with Staphylococcus aureus nasal carriage in peritoneal dialysis patients. Perit Dial Int 1993; 13 (suppl. 2): S332–S334.PubMedGoogle Scholar
  66. 66.
    Bernadini J. Peritoneal dialysis catheter complications. Perit Dial Int 1996; 16 (suppl. 1): S468–S471.Google Scholar
  67. 67.
    Gong WK, Foong PP, Ramirez S, Nurugasu B, Yap HK. Can dialysis adequacy be achieved by tailoring the dialysis prescription in an Asian pediatric population on nightly intermittent peritoneal dialysis? Adv Perit Dial 1999; 15: 291–296.PubMedGoogle Scholar
  68. 68.
    Fine RN. Growth in children with renal insufficiency. In: Nissenson AR, Fine RN, Gentile DE, eds. Clinical Dialysis. Norwalk, Connecticut: Appleton and Lange, 1990: 667–675.Google Scholar
  69. 69.
    Foster BJ, Leonard MB. Nutrition in children with kidney disease: Pitfalls of popular assessment methods. Perit Dial Int 2005; 25 (suppl. 3): S143–S146.PubMedGoogle Scholar
  70. 70.
    Fried L, Piraino B. Peritonitis. In: Gokal R, Khanna R, Krediet R, Nolph K, eds. Textbook of Peritoneal Dialysis. 2nd Ed., Dordrecht: Kluwer Academic, 2000: 545–564.Google Scholar
  71. 71.
    Woodrow G, Turney JH, Brownjohn AM. Technique failure in peritoneal dialysis and its impact on patient survival. Perit Dial Int 1997; 17: 360–364.PubMedGoogle Scholar
  72. 72.
    Fox L, Tzamaloukas AH, Murata GH. Metabolic differences between persistent and routine peritonitis in CAPD. Adv Perit Dial 1992; 8: 346–350.PubMedGoogle Scholar
  73. 73.
    Fried L, Bernardini J, Johnston JR, Piraino B. Peritonitis influences mortality in peritoneal dialysis patients. J Am Soc Nephrol 1996; 7: 2176–2182.PubMedGoogle Scholar
  74. 74.
    Krishnan M, Thodis E, Ikonomopoulos D, et al. Predictors of outcome following bacterial peritonitis in peritoneal dialysis. Perit Dial Int 2002; 22: 573–581.PubMedGoogle Scholar
  75. 75.
    Sahu KM, Gupta A, Sharma RK, Prasad KN, Sharma AP. Fungal peritonitis in CAPD. Indian J Perit Dial 2000; 3: 25–28.Google Scholar
  76. 76.
    Murata GH, Fox L, Tzamaloukas AH. Predicting the course of peritonitis in patients receiving continuous ambulatory peritoneal dialysis. Arch Intern Med 1993; 153: 2317–2321.PubMedGoogle Scholar
  77. 77.
    Tzamaloukas AH. What affects the outcome of peritoneal dialysis? Going beyond the microbial etiology. Perit Dial Int 2002; 22: 563–565.PubMedGoogle Scholar
  78. 78.
    Subramanian J, Padma G, Uma S, Abraham G, Soundararajan P. Nasal carriage of Staphylococcus aureus in chronic peritoneal dialysis patients at a tertiary-care center. Indian J Perit Dial 2005; 8: Abstract S23.Google Scholar
  79. 79.
    Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, et al. Peritoneal dialysis-related infections recommendations: 2005 Update. Perit Dial Int 2005; 25: 107–131.PubMedGoogle Scholar
  80. 80.
    Lye WC, van der Straaten JC, Leong SO, Sivaraman P, et al. Once-daily intraperitoneal gentamicin is effective therapy for gram-negative CAPD peritonitis. Perit Dial Int 1999; 19: 357–360.PubMedGoogle Scholar
  81. 81.
    Mathe H, Craig WA, Pechere PC. Determinants of efficacy and toxicity of aminoglycosides. J Antimicrob Chemother 1989; 24: 182–193.Google Scholar
  82. 82.
    Voges M, Faict D, Lechien G, Taminne M. Stability of drug additives in peritoneal dialysis solutions in a new container. Perit Dial Int 2004; 23: 590–595.Google Scholar
  83. 83.
    Mathew M, Srinivasan D, Abraham G, Sekar U, Shroff S. Catheter loss and reimplantation in chronic peritoneal dialysis patients – South Indian experience. Perit Dial Int 2004; 24: Abstract S59.Google Scholar
  84. 84.
    Nagarajan P, Shanmuga Bhaskar S, Mathew M, Lalitha MK, Abraham G. Adhesions following recurrent peritonitis in a failed allograft recipient. Indian J Perit Dial 2006; 11: 35–36.Google Scholar
  85. 85.
    Yilmazlar T, Kirdak T, Bilgin S, Yavuz M, Yurtkuran M. Laparoscopic findings of peritoneal dialysis catheter malfunction and management outcomes. Perit Dial Int 2006; 26: 374–379.PubMedGoogle Scholar
  86. 86.
    Wright MJ, Beleed K, Johnson BF, Eadington DW, et al. Randomized prospective comparison of laparoscopic and open peritoneal dialysis catheter insertion. Perit Dial Int 1999; 19: 372–375.PubMedGoogle Scholar
  87. 87.
    Wang AYM, Yu AWY, Li PKT, et al. An analysis of a nine-year trend of fungal peritonitis in CAPD patients. Perit Dial Int 1998; 18 (suppl. 2): S75.Google Scholar
  88. 88.
    Cheng IK, Fang GX, Chan TM, Chan PC, Chan MK. Fungal peritonitis complicating peritoneal dialysis: a report of 25 cases and review of treatment. Q J Med 1989; 71: 407–416.PubMedGoogle Scholar
  89. 89.
    Lopes JO, Alves SH, Benevenga JP, Rosa AL. The second case of peritonitis due to Histoplasma capsulatum. Mycoses 1994; 37: 161–163.PubMedGoogle Scholar
  90. 90.
    Chan TH, Koehler A, Li PK. Paecilomyces varioti peritonitis in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1996; 27: 138–142.PubMedGoogle Scholar
  91. 91.
    Chan TM, Chan CY, Cheng SW, et al. Treatment of fungal peritonitis complicating ambulatory peritoneal dialysis with fluconazole: a series of 21 patients. Nephrol Dial Transplant 1994; 9: 539–542.PubMedGoogle Scholar
  92. 92.
    Lee SH, Chiang SS, Hseih SJ, Shen HM. Intra catheter amphotericin B retention for fungal peritonitis in continuous ambulatory peritoneal dialysis. J Formos Med Assoc 1995; 94: 132–134.PubMedGoogle Scholar
  93. 93.
    Lo WK, Chan CY, Cheng SW, Poon JF. A prospective randomized control study of oral nystatin prophylaxis for Candida peritonitis complicating continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1996; 28: 549–552.PubMedGoogle Scholar
  94. 94.
    Ram R, Prasad N, Dakshinamurty KV. Mycobacterial peritonitis in patients on CAPD. Indian J Perit Dial 2006; 11: 28–31.Google Scholar
  95. 95.
    Abraham G, Mathew M, Sekhar L, Aparajitha, et al. Tuberculous peritonitis in a cohort of CAPD patients. Perit Dial Int 2001; 21 (suppl. 3): 2002–2004.Google Scholar
  96. 96.
    Liu SL, Tang S, Li FK, Choy BY, et al. Tuberculosis infection in Chinese patients undergoing CAPD. Am J Kidney Dis 2001; 38 (5): 1055–1060.Google Scholar
  97. 97.
    Lam MF, Tang SCW, Lai KN. Tuberculosis peritonitis in patients on CAPD. Int J Artif Organs 2000; 23: 154–156.PubMedGoogle Scholar
  98. 98.
    Matthew M, Pratap B, Govindan P, Sekar U, Ramalakshmi R, Suresh S, Baskar S, Abraham G. Rapid Diagnosis of TB peritonitis in peritoneal dialysis patients using molecular techniques. Perit Dial Int 2006; 26 (suppl. 2): Abstract S58.Google Scholar
  99. 99.
    Abu-Aisha H, Mandour M, El Awad K, Kaballo B, et al. One year experience with a multi-center integrated peritoneal dialysis program in the Sudan. Indian J Perit Dial 2006; 11: 14–18.Google Scholar
  100. 100.
    Duman S, Gunal AI, Sen S, Asci G, et al. Does enalapril prevent peritoneal fibrosis induced by hypertonic (3.86%) peritoneal dialysis solution? Perit Dial Int 2001; 21: 219–224.PubMedGoogle Scholar
  101. 101.
    Devi TL, Abraham G, Mathew M, Perambalam A, et al. Renal replacement therapy in HIV positive patients: experience with CAPD. Indian J Perit Dial 2005; 8: 20–22.Google Scholar
  102. 102.
    McLigeyo SO. Initial experience with CAPD in patients with HIV infection in a developing country. Perit Dial Int 1992; 12: 267–268.PubMedGoogle Scholar
  103. 103.
    Abraham G, Ravi R, Venkat R, et al. Successful use of CAPD as ESRD treatment in a HIV patient. J Assoc Physicians India 1994; 42: 828–829.PubMedGoogle Scholar
  104. 104.
    Hung KY, Shyu RS, Huang CH, Tsai TJ, Chen WY. Viral hepatitis in continuous ambulatory peritoneal dialysis patients in an endemic area for hepatitis B and C infection: the Taiwan experience. Blood Purif 1997; 15: 195–199.PubMedGoogle Scholar
  105. 105.
    Cendoroglo Neto M, Draibe SA, Silva AE, et al. Incidence of and risk factors for hepatitis B virus and hepatitis C virus infection among haemodialysis and CAPD patients: evidence for environmental transmission. Nephrol Dial Transplant 1995; 10: 240–246.PubMedGoogle Scholar
  106. 106.
    Vanderborght BO, Rouzere C, Ginuino CF, et al. High prevalence of hepatitis C infection among Brazilian haemodialysis patients in Rio de Janeiro: a one year follow up study. Rev Inst Med Trop Sao Paulo, 1995; 37: 75–79.PubMedGoogle Scholar
  107. 107.
    Hung KY, Shyu RS, Tsai TJ, Chen WY. Viral hepatitis infection should be considered for evaluating uremic pruritus in continuous ambulatory peritoneal dialysis patients. Blod Purif 1998; 16: 147–153.Google Scholar
  108. 108.
    Hung KY, Lee KC, Yen CJ, et al. Revised cutoff values of serum aminotransferase in detecting viral hepatitis among CAPD patients: experience from Taiwan, an endemic area for hepatitis B. Nephrol Dial Transplant 1997; 12: 180–183.PubMedGoogle Scholar
  109. 109.
    Huang CC, Wu MS, Lin DY, Liaw YF. The prevalence of hepatitis C virus antibodies in patients treated with continuous ambulatory peritoneal dialysis. Perit Dial Int 1992; 12: 31–33.PubMedGoogle Scholar
  110. 110.
    Ng YY, Lee SD, Wu SC, et al. The need for second generation anti-hepatitis C virus testing in uremic patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 193; 13: 132–135.Google Scholar
  111. 111.
    Nakashima F, Sate M, Takeshi S, et al. Incidence of antibodies to hepatitis C virus in patients undergoing chronic dialysis or CAPD. Kurume Med J 1993; 40: 249–253.PubMedGoogle Scholar
  112. 112.
    Taduri G, Murthy KV, Tillalamarri MT, Lakshmi M, et al. Avoidance of HCV transmission: A major advantage for PD in an Indian center. Perit Dial Int 2005; 25: 605–606.PubMedGoogle Scholar
  113. 113.
    Huang CH, Kao JH, Kuo YM, et al. GB virus C/hepatitis G virus infection in patients on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1988; 13: 2914–2919.Google Scholar
  114. 114.
    Noh H, Kang SW, Choi SH, et al. Hepatitis G virus infection in hemodialysis and continuous ambulatory peritoneal dialysis patients. Yonsei Med J 1998; 39: 116–121.PubMedGoogle Scholar
  115. 115.
    Kim BS, Park JH, Shin YS, et al. The incidence and clinical impact of hepatitis G virus infection in peritoneal dialysis and haemodialysis patients. Perit Dial Int 1998; 18 (suppl. 2): S12.Google Scholar
  116. 116.
    Young GA, Kopple JB, Lindholm B, et al. Nutritional assessment of CAPD patients: an interpersonal study. Am J Kidney Dis 1991; 17: 462–71.PubMedGoogle Scholar
  117. 117.
    Guo D, Wang G, Jiang Y. Assessment of the nutritional status in 52 cases of CAPD patients. Perit Dial Int 1998; 18 (suppl. 2): S53.Google Scholar
  118. 118.
    Harty J, Gokal R. Nutritional status in PD. J Renal Nutr 1995; 5: 2–10.Google Scholar
  119. 119.
    Tan SH, Lee EJC, Tay ME, Leo BK. Protein nutrition status of adult patients starting chronic ambulatory peritoneal dialysis. Adv Perit Dial 2000; 16: 291–293.PubMedGoogle Scholar
  120. 120.
    Kaysen G. Serum albumin concentration in dialysis patients: why does it remain resistant to therapy? Kidney Int Suppl 2003; 87: S92–S98.PubMedGoogle Scholar
  121. 121.
    Pinlac G, Danguclan RA. Nutritional parameters in new CAPD patients. Perit Dial Int 1998; 18 (suppl. 2): S52.Google Scholar
  122. 122.
    Jayanthi V, Ravichandran P, Abraham G. Nutritional problems in patients on CAPD. Perit Dial Int 1998; 18 (suppl. 2): S49.Google Scholar
  123. 123.
    Espinoso A, Cueto Manzano AM, Velazquez Alva C, et al. Prevalence of malnutrition in Mexican CAPD diabetic and nondiabetic patients. Adv Perit Dial 1996; 12: 302–306.Google Scholar
  124. 124.
    Hong D. Nutritional status in CAPD patients. Perit Dial Int 1998; 18 (suppl. 2): S52.Google Scholar
  125. 125.
    Gamba G, Mejia JL, Saldivav S, et al. Death risk in CAPD patients. The predictive values of the initial clinical and laboratory variables. Nephron 1993; 65: 23–27.PubMedGoogle Scholar
  126. 126.
    Yuan B, Zhang Y, Chen X, et al. The influence of dietary management on nutritional status in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1998; 18 (suppl. 2): S51.Google Scholar
  127. 127.
    Chen TP, Lee HP. Oral nutritional supplement improves nutritional status of CAPD patients. Perit Dial Int 1998; 18 (suppl. 2): S50.Google Scholar
  128. 128.
    Kong W. Clinical observation of CAPD patients nutritional condition in the use of Chinese traditional medicine. Perit Dial Int 1998; 18 (suppl. 2): S52.Google Scholar
  129. 129.
    Christie S, Small S, Williams P. Megestrol Acetate: A new weapon to treat malnutrition in the PD patient? Perit Dial Int 2001; 21 (suppl. 1): Abstract S46.Google Scholar
  130. 130.
    Ates K, Oztemel A, Nergizoglu G, Erturk S, et al. Peritoneal protein losses do not have a significant impact on nutritional status in CAPD patients. Perit Dial Int 2001; 21: 519–522.PubMedGoogle Scholar
  131. 131.
    Locatelli F, Fouque D, Heimburger O, Drueke TB, et al. Nutritional status in dialysis patients: A European consensus. Nephrol Dial Transplant 2002; 17: 563–572.PubMedGoogle Scholar
  132. 132.
    Jayanthi V. Vegetarianism in India. Perit Dial Int 2001; 21: s322–S325.PubMedGoogle Scholar
  133. 133.
    Ramalakshmi S, Baben B, Ashok BS, Jayanthi V, Leslie N, Abraham G. Association of carnitine deficiency in Indian continuous ambulatory peritoneal dialysis patients with anemia, erythropoietin use, residual renal function, and diabetes mellitus.. Perit Dial Int 2007; 27 (suppl. 2): S235–S238.PubMedGoogle Scholar
  134. 134.
    Janakiraman H, Mathew M, Abraham G, Baben BJ, et al. Prevalence of 25(OH) Vitamin D deficiencies in chronic kidney disease patients on PD in South India. Perit Dial Int 2006; 26 (suppl. 2): Abstract S70.Google Scholar
  135. 135.
    Cueto-Manzano AM, Correa-Rotter R. Is high peritoneal transport rate an independent risk factor for CAPD mortality? Kidney Int 2000; 57: 314–320.PubMedGoogle Scholar
  136. 136.
    Chung SH, Heimburger O, Stenvinkel P, Wang T, Lindholm B. Influence of peritoneal transport rate, inflammation, and fluid removal on nutritional status and clinical outcome in prevalent peritoneal dialysis patients. Perit Dial Int 2003; 23: 174–183.PubMedGoogle Scholar
  137. 137.
    Cueto-Manzano AM, Rojas-Campos E, Martinez-Ramirez HR, et al. Can the inflammation markers of patients with high peritoneal permeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis? Perit Dial Int 2006; 26: 341–348.PubMedGoogle Scholar
  138. 138.
    Avila-Diaz M, Ventura M, Valle D, Vicente-Martinez M, et al. Inflammation and extracellular volume expansion are related to sodium and water removal in patients on peritoneal dialysis. Perit Dial Int 2006; 26: 574–580.PubMedGoogle Scholar
  139. 139.
    Kohli R, Gupta A, Sharma RK, Singh U. Profile of patients initiating on continuous ambulatory peritoneal dialysis: single center experience. Indian J Perit Dial 2004; 6: 15–18.Google Scholar
  140. 140.
    Abraham G, Varsha, Mathew M, Sairam VK, Gupta A. Malnutrition and nutritional therapy of chronic kidney disease in developing countries – the Asian perspective. Adv Ren Replace Ther 2003; 10: 213–221.PubMedGoogle Scholar
  141. 141.
    Grzegorzewska AE, Wiecek A, Mariak I, Kokot F. Amino-acid-based dialysis solution changes leptinemia and leptin peritoneal clearance. Adv Perit Dial 2000; 16: 7–14.PubMedGoogle Scholar
  142. 142.
    Grzegorzewska AE, Antczak-Jedrzejczak D, Mariak I. Polyglucose dialysis solution influences serum iron parameters. Adv Perit Dial 2000; 16: 73–79.PubMedGoogle Scholar
  143. 143.
    Valmoorthi S, Rajan S, Dhas LK, et al. Successful coronary revascularization surgery in a diabetic CAPD patients followed by renal transplantation. Indian J Perit Dial 2005; 8: 23–24.Google Scholar
  144. 144.
    Abraham G, Blake P, David T, Oreopoulos DG. Decreased morbidity in peritoneal dialysis patients undergoing coronary artery bypass graft. Perit Dial Int 1989; 9: 355–356.PubMedGoogle Scholar
  145. 145.
    Thakar CV, Worley S, Arrigain S, et al. Influence of renal dysfunction on mortality after cardiac surgery: modifying effects of preoperative renal function. Kidney Int 2005; 67: 1112–1119.PubMedGoogle Scholar
  146. 146.
    Locatelli F, Marcelli D, Conte F, et al. Survival and development of cardiovascular disease by modality of treatment in patients with end-stage renal disease. J Am Soc Nephrol 2001; 12: 2411–2417.PubMedGoogle Scholar
  147. 147.
    Ganesh SK, Hulbert-Shearon T, Port FK, et al. Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease. J Am Soc Nephrol 2003; 14: 415–424.PubMedGoogle Scholar
  148. 148.
    Tonbul Z, Altintepe L, Sozlu C, Yeksan M, Yildiz A, Turk S. The association of peritoneal transport properties with 24-hour blood pressure levels in CAPD patients. Perit Dial Int 2003; 23: 46–52.PubMedGoogle Scholar
  149. 149.
    Van Biesen W, Vanholder R, Verbeke F, Lameire N. Is peritoneal dialysis associated with increased cardiovascular morbidity and mortality? Perit Dial Int 2006; 26: 429–434.PubMedGoogle Scholar
  150. 150.
    Mathew M, Srinivasan D, Abraham G, Sekar U, Shroff S. Cardiac outcome in CKD, hemodialysis and chronic peritoneal dialysis patients. Perit Dial Int 2004; 24 (suppl. 2): Abstract S42.Google Scholar
  151. 151.
    Wanner C, Zimmermann J, Schwedler S, Metzger T. Inflammation and cardiovascular risk in dialysis patients. Kidney Int Suppl 2002; 80: S99–S102.Google Scholar
  152. 152.
    Niebauer J, Volk HD, Kemp M, et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 1999; 353: 1838–1842.PubMedGoogle Scholar
  153. 153.
    Tang W, Wang T. Malnutrition, Inflammation and cardiovascular disease in diabetic peritoneal dialysis patients. Indian J Perit Dial 2005; 9: 34–37.Google Scholar
  154. 154.
    Yao Q, Lin AW, Gu AP, et al. High morbidity and unsatisfied treatment of metabolic complications in peritoneal dialysis patients with conventional solution. Perit Dial Int 2006; 26 (suppl. 2): Abstract S75.Google Scholar
  155. 155.
    Kanbay M, Kaya A, Aydogan T, et al. Effect of peritoneal dialysis solution type on serum lipid levels in end-stage renal disease. Perit Dial Int 2006; 26 (suppl. 2): Abstract S77.Google Scholar
  156. 156.
    Bloembergen WE, Prot FK, MAuger EA, Wolfe RA. A comparison of cause of death between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1995; 6: 184–191.PubMedGoogle Scholar
  157. 157.
    Tomura S, Nakamura Y, Doi M, Ando R, Ida T, Chida Y, et al. Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1 and lipid as cardiovascular risk factors in chronic hemodialysis and CAPD patients. Am J Kidney Dis 1996; 27: 848–854.PubMedGoogle Scholar
  158. 158.
    Balaskas EV, Sioulis A, Patrikalou E, et al. The effect of atorvastatin on hyperlipidemia in CAPD patients. Perit Dial Int 2002; 22: Abstract S42.Google Scholar
  159. 159.
    Bazzal I, Pilotovich VS, Voitovich VA. Control of hyperlipidemia in patients on renal replacement therapy. Perit Dial Int 2002; 22: Abstract S42.Google Scholar
  160. 160.
    Malyszko J, Malyszko JS, Hryszko T, Mysliwiec M. Influence of Simvastatin on aspects of thrombogenesis in CAPD patients. Perit Dial Int 2003; 23: 260–266.PubMedGoogle Scholar
  161. 161.
    Lindberg JS, Moe SM. Osteoporosis in end-stage renal disease. Semin Nephrol 1999; 19: 115–122.PubMedGoogle Scholar
  162. 162.
    Fontaine MA, Albert A, Dubois B, Saint-Remy A, Rorive G. Fracture and bone mineral density in hemodialysis patients. Clin Nephrol 2000; 54: 218–226.PubMedGoogle Scholar
  163. 163.
    Benedik M, Gucek A. Low Vitamin D Status in peritoneal dialysis patients is not dependent on transport status of peritoneal membrane. Perit Dial Int 2006; 26 (suppl. 2): Abstract S68.Google Scholar
  164. 164.
    Dong J, Wang M, Wang HY. The low prevalence of hyperphosphatemia in a Chinese peritoneal dialysis center. Perit Dial Int 2006; 26 (suppl. 2): Abstract S69.Google Scholar
  165. 165.
    Hercz G, Coburn JW. Prevention of phosphate retention and hyperphosphatemia in uremia. Kidney Int Suppl 1987; 22: S215–S220.PubMedGoogle Scholar
  166. 166.
    Katopodis KP, Andrikos EK, Gouva CD, et al. Sevelamer hydrochloride versus aluminum hydroxide: effect on serum phosphorous and lipids in CAPD patients. Perit Dial Int 2006; 26: 320–327.PubMedGoogle Scholar
  167. 167.
    Ueda M, Inaba M, Okuno S, Nagasue K, et al. Clinical usefulness of serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patients. Am J Kidney Dis 2002; 40: 802–809.PubMedGoogle Scholar
  168. 168.
    Negri AL, Quiroga MA, Bravo M, Marino A, et al. Serum crosslaps as bone resorption marker in peritoneal dialysis. Perit Dial Int 2002; 22: 628–629.PubMedGoogle Scholar
  169. 169.
    Naghibi M, Nazemian F, Tavakoli V. Parathyroid hormone and biochemical profile in chronic kidney disease patients in Iran. Perit Dial Int 2006; 26: Abstract S73.Google Scholar
  170. 170.
    Negri AL, Barone R, Quiroga MA, et al. Bone mineral density: serum markers of bone turnover and their relationships in peritoneal dialysis. Perit Dial Int 2004; 24: 163–168.PubMedGoogle Scholar
  171. 171.
    Baszko-Blaszyk D, Grzegorzewska AE, Horst-Sikorska W, Sowinski J. Bone mass in chronic renal insufficiency patients treated with continuous ambulatory peritoneal dialysis. Am J Kidney Dis 2002; 39: 580–6.Google Scholar
  172. 172.
    Fahath SJ, Karpagavalli SP, Abraham G. Comparative study of nutritional assessment dialysis adequacy, inflammation and anthropometry in a cohort of hemodialysis and peritoneal dialysis patients. Indian J Perit Dial 2005; 8: Abstract S13.Google Scholar
  173. 173.
    Pollock CA. The impact of guidelines for the prevention of anemia on clinical outcome. Perit Dial Int 2005; 25 (suppl. 3): S99–S101.PubMedGoogle Scholar
  174. 174.
    Abraham G, Padma G, Mathew M, Shroff S. How to set up a peritoneal dialysis program: Indian experience. Perit Dial Int 1999; 19 (suppl. 2): S184–S186.PubMedGoogle Scholar
  175. 175.
    Chan MK, Lam SS, Chin KW. Continuous ambulatory peritoneal dialysis (CAPD) in diabetic patients with end stage renal failure in Hong Kong. J Diabets Complication 1987; 1: 11–15.Google Scholar
  176. 176.
    Wei SS, Lee GS, Woo KT, LiM CH. Continuous ambulatory peritoneal dialysis in Type II diabetics. Ann Acad Med Singap 1993; 22: 629–633.PubMedGoogle Scholar
  177. 177.
    Lee HB. Dialysis in patients with diabetic nephropathy: CAPD vs HD. Perit Dial Int 1996; 16 (suppl. 1): S269–S274.PubMedGoogle Scholar
  178. 178.
    Wu MS, Yu CC, Wu CH, et al. Predialysis glycemic control is an independent predictor of mortality in type II diabetic patient on CAPD. Perit Dial Int 1998; 18 (suppl. 2): S10.Google Scholar
  179. 179.
    Blake PG, Breborowicz A, Han DS, Joffe P, Korbet SM, Warady BA. Recommended peritoneal dialysis curriculum for nephrology trainees. The International Society for Peritoneal Dialysis (ISPD) Standards and Education Subcommittee. Perit Dial Int 2000; 20: 497–502.PubMedGoogle Scholar
  180. 180.
    Piccoli GB, Mezza E, Soragna G, Paciti A, et al. Teaching Peritoneal Dialysis in Medical School: An Italian Pilot experience. Perit Dial Int 2003; 23: 296–302.PubMedGoogle Scholar
  181. 181.
    Souqiyyeh MZ, Shaheen FAM. Survey of the attitude of physicians towards establishing and maintaining a peritoneal dialysis program. Saudi J Kidney Dis Transplant 2006; 17 (3): 355–364.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Sri Ramachandra Medical College and Research InstituteChennaiIndia
  2. 2.Sri Ramachandra UniversityChennaiIndia
  3. 3.Sanjay Gandhi Postgraduate Institute of Medical SciencesLucknowIndia

Personalised recommendations